A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy-Reference-Cited by-同舟云学术

A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy

Published:2022-11 Issue:6 Volume:7 Page:101024
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Patel Krishnan R.^ORCID,Rowe Lindsay S.,Schott Erica,Cooley-Zgela Theresa,Ning Holly,Turkbey Baris,Choyke Peter,Lindenberg Liza,Mena Esther,Pinto Peter A.,Zhang Qihu,Shih Joanna,Salerno Kilian E.,Citrin Deborah E.

Funder

National Institutes of Health Clinical Center

National Institutes of Health

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference46 articles.

1. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012;Butler;Cancer,2020

2. Trends in diagnosis and disparities in initial management of high-risk prostate cancer in the US;Agrawal;JAMA Netw Open,2020

3. Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer;Kaps;Cancer Med,2020

4. Factors influencing noncompletion of radiation therapy among men with localized prostate cancer;Dee;Int J Radiat Oncol Biol Phys,2021

5. Financial toxicity associated with treatment of localized prostate cancer;Imber;Nat Rev Urol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiation therapy after radical prostatectomy: current status and future directions;World Journal of Urology;2023-09-19